Stock Update: Gilead Sciences Inc (NASDAQ:GILD) – Gilead Sciences to Present at the 36th Annual William Blair Growth Stock Conference on Tuesday, June 14

[Business Wire] – Gilead Sciences, Inc. today announced that its corporate presentation will be webcast from the 36th Annual William Blair Growth Stock Conference in Chicago. Read more on this. Gilead Sciences Inc. (GILD) , valued at $111.85B, started trading this morning at $84.00. Today’s price range has been between $83.90 and $84.81 per share with the price of the stock fluctuating between $81.28 to $123.37 over the last 52 weeks. GILD shares are currently priced at 7.00x this year’s forecasted earnings, which makes them relatively inexpensive compared to the industry’s 13.21x earnings multiple for the same period. The company pays shareholders $1.88 per share in dividend income per year, for a current yield of 2.23%. In a review of the consensus earnings estimate this quarter, 20 sell-side analysts are looking at $2.99 per share, which would be $0.16 worse than the year-ago quarter and a $0.06 sequential decrease. In looking at the bigger picture, the full-year EPS estimate of $12.06 would be a $0.55 worse when compared to the previous year’s annual results. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $7.77 Billion. If realized, that would be a 5.70% decrease over the year-ago quarter. Recently, Gabelli & Co Initiated GILD at Buy (Jun 1, 2016). Previously, Maxim Group downgraded GILD from Buy to Hold. When considering if perhaps the stock is under or overvalued, the average price target is $110.89, which is 32.01% above where the stock opened this morning. See more in (NASDAQ:GILD) Similar Articles: Company Update (NASDAQ:GILD): Gilead Sciences to Present at the Jefferies 2016 Healthcare Conference on Friday, June 10 Market Update: Gilead Sciences Inc (NASDAQ:GILD) – Gilead Sciences to Present at the Bank of America Merrill Lynch Healthcare Conference on Tuesday, May 10 Company Update (NASDAQ:GILD): Gilead Sciences to Present at the Cowen & Company 36th Annual Health Care Conference on Monday, March 7